Donald Bobo, Jr Biography and Net Worth
Donald E. Bobo, Jr., has been corporate vice president since 2007 and is currently responsible for the company’s corporate strategy and corporate development functions. In addition, Bobo has executive responsibility for disease awareness and heart failure initiatives as well as the healthcare solutions and commercial services team. Bobo has more than 30 years of experience in the medical products and healthcare industry in various leadership roles at Edwards including, most recently, the development of the company’s Transcatheter Mitral and Tricuspid Therapies organization, vice president and general manager of the Surgical Structural Heart business and global valve manufacturing operations. Prior to joining Edwards, Bobo held a variety of roles with increasing levels of responsibilities with American Hospital Supply and Baxter Healthcare, including research and development, business development, operations and general management. He has served as board chairman of the California Life Sciences Association (CLSA). Bobo received a bachelor's degree in mathematics from Bob Jones University, and a master's degree in engineering from the University of Southern California.
What is Donald E. Bobo, Jr's net worth?
The estimated net worth of Donald E. Bobo, Jr is at least $4.85 million as of November 8th, 2022. Mr. Bobo, Jr owns 62,561 shares of Edwards Lifesciences stock worth more than $4,852,231 as of December 1st. This net worth evaluation does not reflect any other assets that Mr. Bobo, Jr may own. Learn More about Donald E. Bobo, Jr's net worth.
How do I contact Donald E. Bobo, Jr?
Has Donald E. Bobo, Jr been buying or selling shares of Edwards Lifesciences?
During the last quarter, Donald E. Bobo, Jr has sold $1,603,643.50 in Edwards Lifesciences stock. Most recently, Donald E. Bobo, Jr. sold 6,725 shares of the business's stock in a transaction on Tuesday, November 8th. The shares were sold at an average price of $68.46, for a transaction totalling $460,393.50. Following the completion of the sale, the vice president now directly owns 62,561 shares of the company's stock, valued at $4,282,926.06. Learn More on Donald E. Bobo, Jr's trading history.
Who are Edwards Lifesciences' active insiders?
Edwards Lifesciences' insider roster includes Donald Bobo, Jr (VP), Daveen Chopra (VP), Kieran Gallahue (Director), Leslie Heisz (Director), Jean-Luc Lemercier (VP), Martha Marsh (Director), Michael Mussallem (CEO), Robert Sellers (VP), Catherine Szyman (VP), Scott Ullem (CFO), Nicholas Valeriani (Director), Huimin Wang (VP), Larry Wood (VP), and Bernard Zovighian (VP). Learn More on Edwards Lifesciences' active insiders.
Are insiders buying or selling shares of Edwards Lifesciences?
In the last year, insiders at the medical research company sold shares 44 times. They sold a total of 636,065 shares worth more than $66,387,065.18. The most recent insider tranaction occured on November, 15th when VP Daveen Chopra sold 4,000 shares worth more than $296,720.00. Insiders at Edwards Lifesciences own 1.3 % of the company. Learn More about insider trades at Edwards Lifesciences.
Information on this page was last updated on 11/15/2022.
Donald E. Bobo, Jr Insider Trading History at Edwards Lifesciences
|Transaction Date||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
Edwards Lifesciences Company Overview
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
50 Day Range
2 Week Range